ESC 365 - Welcome and introduction.

ESC Premium Access

Welcome and introduction.

Session: Evolving role of SGLT2i in HFrEF management

Topic: Pharmacotherapy

Speaker: Professor C. Lam (Singapore, SG)

Sponsored by AstraZeneca

Event: ESC Asia with APSC & AFC 2021

Congress Session

About the speaker

Professor Carolyn Sp Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)

102 presentations

16 followers

3 more presentations in this session

Emerging evidence for SGLT2i in HFrEF patients.

Speaker: Doctor P. Kumar Sahoo (Bhubaneswar, IN)

SGLT2i in ESC 2021 HF management guideline - clinical implication.

Speaker: Doctor J. Kang (Seoul, KR)

Discussion and live Q&A.

Access the full session

Evolving role of SGLT2i in HFrEF management

Speakers: Professor C. Lam, Doctor P. Kumar Sahoo, Doctor J. Kang

About the event

ESC Asia with APSC & AFC 2021

2 December - 4 December 2021

Sessions Presentations

Congress

Related content

Open Access

Evidence-based strategies to achieve low-risk status.

27 August 2021

ESC Premium Access

Approach to the patient with pulmonary hypertension: essential knowledge.

27 August 2021

Open Access

Your treatment approach in clinical practice.

27 August 2021

This platform is supported by